nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE4A—chronic obstructive pulmonary disease	0.462	1	CbGaD
Tofisopam—PDE4A—Roflumilast—chronic obstructive pulmonary disease	0.22	0.433	CbGbCtD
Tofisopam—PDE3A—Aminophylline—chronic obstructive pulmonary disease	0.127	0.25	CbGbCtD
Tofisopam—PDE4A—Aminophylline—chronic obstructive pulmonary disease	0.12	0.237	CbGbCtD
Tofisopam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0116	0.0228	CbGbCtD
Tofisopam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00784	0.0154	CbGbCtD
Tofisopam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00748	0.0147	CbGbCtD
Tofisopam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00666	0.0131	CbGbCtD
Tofisopam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00391	0.0077	CbGbCtD
Tofisopam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00369	0.00727	CbGbCtD
Tofisopam—PDE2A—Nitric oxide stimulates guanylate cyclase—NOS2—chronic obstructive pulmonary disease	0.00121	0.0434	CbGpPWpGaD
Tofisopam—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00107	0.0383	CbGpPWpGaD
Tofisopam—PDE2A—Nitric oxide stimulates guanylate cyclase—NOS3—chronic obstructive pulmonary disease	0.000971	0.0349	CbGpPWpGaD
Tofisopam—PDE2A—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000948	0.034	CbGpPWpGaD
Tofisopam—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000943	0.0339	CbGpPWpGaD
Tofisopam—PDE10A—Nitric oxide stimulates guanylate cyclase—NOS2—chronic obstructive pulmonary disease	0.000915	0.0329	CbGpPWpGaD
Tofisopam—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000771	0.0277	CbGpPWpGaD
Tofisopam—PDE10A—Nitric oxide stimulates guanylate cyclase—NOS3—chronic obstructive pulmonary disease	0.000736	0.0264	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000718	0.0258	CbGpPWpGaD
Tofisopam—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS2—chronic obstructive pulmonary disease	0.000539	0.0194	CbGpPWpGaD
Tofisopam—PDE2A—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.000479	0.0172	CbGpPWpGaD
Tofisopam—PDE10A—respiratory system—chronic obstructive pulmonary disease	0.000478	0.255	CbGeAlD
Tofisopam—Verapamil—SLC6A4—chronic obstructive pulmonary disease	0.000474	0.523	CrCbGaD
Tofisopam—PDE2A—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.00047	0.0169	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000464	0.0167	CbGpPWpGaD
Tofisopam—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS3—chronic obstructive pulmonary disease	0.000434	0.0156	CbGpPWpGaD
Tofisopam—Verapamil—CYP1A2—chronic obstructive pulmonary disease	0.000432	0.477	CrCbGaD
Tofisopam—PDE3A—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000423	0.0152	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000406	0.0146	CbGpPWpGaD
Tofisopam—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000391	0.0141	CbGpPWpGaD
Tofisopam—PDE2A—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.000378	0.0136	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.000363	0.013	CbGpPWpGaD
Tofisopam—PDE10A—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.000356	0.0128	CbGpPWpGaD
Tofisopam—PDE2A—trachea—chronic obstructive pulmonary disease	0.000353	0.188	CbGeAlD
Tofisopam—PDE10A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000352	0.0126	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000308	0.011	CbGpPWpGaD
Tofisopam—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.0003	0.0108	CbGpPWpGaD
Tofisopam—PDE10A—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.000286	0.0103	CbGpPWpGaD
Tofisopam—PDE10A—lung—chronic obstructive pulmonary disease	0.000254	0.135	CbGeAlD
Tofisopam—PDE2A—lung—chronic obstructive pulmonary disease	0.000254	0.135	CbGeAlD
Tofisopam—PDE2A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000233	0.00837	CbGpPWpGaD
Tofisopam—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000233	0.00835	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000227	0.00816	CbGpPWpGaD
Tofisopam—PDE4A—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.00022	0.0079	CbGpPWpGaD
Tofisopam—PDE3A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000219	0.117	CbGeAlD
Tofisopam—PDE3A—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.000214	0.00769	CbGpPWpGaD
Tofisopam—PDE3A—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.00021	0.00754	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000207	0.00745	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000202	0.00726	CbGpPWpGaD
Tofisopam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000202	0.00726	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000194	0.00698	CbGpPWpGaD
Tofisopam—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000184	0.0066	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000181	0.00651	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000181	0.00651	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000177	0.00635	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000177	0.00634	CbGpPWpGaD
Tofisopam—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.00632	CbGpPWpGaD
Tofisopam—PDE4A—lung—chronic obstructive pulmonary disease	0.000175	0.0931	CbGeAlD
Tofisopam—PDE10A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000172	0.00618	CbGpPWpGaD
Tofisopam—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000169	0.00607	CbGpPWpGaD
Tofisopam—PDE3A—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.000169	0.00606	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000163	0.00587	CbGpPWpGaD
Tofisopam—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000163	0.00584	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000157	0.00563	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000153	0.0055	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000147	0.00529	CbGpPWpGaD
Tofisopam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00527	CbGpPWpGaD
Tofisopam—PDE3A—lung—chronic obstructive pulmonary disease	0.000145	0.077	CbGeAlD
Tofisopam—PDE2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000142	0.00511	CbGpPWpGaD
Tofisopam—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000141	0.00506	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000138	0.00494	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000137	0.00493	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000134	0.00481	CbGpPWpGaD
Tofisopam—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.0048	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000124	0.00445	CbGpPWpGaD
Tofisopam—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00441	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000119	0.00427	CbGpPWpGaD
Tofisopam—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00424	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000117	0.0042	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000115	0.00412	CbGpPWpGaD
Tofisopam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00397	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000108	0.00387	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000105	0.00378	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000104	0.00375	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000104	0.00375	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000104	0.00375	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000104	0.00374	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000101	0.00364	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.83e-05	0.00353	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	9.03e-05	0.00324	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.93e-05	0.00321	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	8.87e-05	0.00319	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ALB—chronic obstructive pulmonary disease	8.85e-05	0.00318	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—MMP1—chronic obstructive pulmonary disease	8.85e-05	0.00318	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.79e-05	0.00315	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—PLAU—chronic obstructive pulmonary disease	8.69e-05	0.00312	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.68e-05	0.00312	CbGpPWpGaD
Tofisopam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	8.68e-05	0.00312	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	8.47e-05	0.00304	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.41e-05	0.00302	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	8.1e-05	0.00291	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—NOS2—chronic obstructive pulmonary disease	7.98e-05	0.00287	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.98e-05	0.00286	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.9e-05	0.00284	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.89e-05	0.00283	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.69e-05	0.00276	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.45e-05	0.00268	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	7.3e-05	0.00262	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.2e-05	0.00258	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.18e-05	0.00258	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.02e-05	0.00252	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7e-05	0.00251	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.98e-05	0.00251	CbGpPWpGaD
Tofisopam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	6.93e-05	0.00249	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.77e-05	0.00243	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	6.72e-05	0.00241	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ALB—chronic obstructive pulmonary disease	6.71e-05	0.00241	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.66e-05	0.00239	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.53e-05	0.00235	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—NOS3—chronic obstructive pulmonary disease	6.42e-05	0.00231	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.37e-05	0.00229	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.36e-05	0.00228	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.32e-05	0.00227	CbGpPWpGaD
Tofisopam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.31e-05	0.00226	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.15e-05	0.00221	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.15e-05	0.00221	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.1e-05	0.00219	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.05e-05	0.00217	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.82e-05	0.00209	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.71e-05	0.00205	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.69e-05	0.00204	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.6e-05	0.00201	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.29e-05	0.0019	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.27e-05	0.00189	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—MMP1—chronic obstructive pulmonary disease	5.22e-05	0.00187	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—PLAU—chronic obstructive pulmonary disease	5.12e-05	0.00184	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.1e-05	0.00183	CbGpPWpGaD
Tofisopam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.03e-05	0.00181	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.75e-05	0.00171	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.71e-05	0.00169	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NOS2—chronic obstructive pulmonary disease	4.71e-05	0.00169	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.66e-05	0.00167	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.66e-05	0.00167	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	4.62e-05	0.00166	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TP53—chronic obstructive pulmonary disease	4.61e-05	0.00166	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.51e-05	0.00162	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.39e-05	0.00158	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.33e-05	0.00156	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.31e-05	0.00155	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.28e-05	0.00154	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	4.24e-05	0.00152	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.13e-05	0.00148	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.12e-05	0.00148	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.1e-05	0.00147	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.03e-05	0.00145	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4e-05	0.00144	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.99e-05	0.00143	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.96e-05	0.00142	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ALB—chronic obstructive pulmonary disease	3.95e-05	0.00142	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.92e-05	0.00141	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.86e-05	0.00139	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.83e-05	0.00138	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.78e-05	0.00136	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.75e-05	0.00135	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.66e-05	0.00132	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.64e-05	0.00131	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.6e-05	0.00129	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.59e-05	0.00129	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.57e-05	0.00128	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.56e-05	0.00128	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.53e-05	0.00127	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TP53—chronic obstructive pulmonary disease	3.49e-05	0.00125	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.43e-05	0.00123	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.27e-05	0.00117	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.25e-05	0.00117	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.2e-05	0.00115	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.15e-05	0.00113	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.12e-05	0.00112	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.12e-05	0.00112	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.02e-05	0.00109	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.01e-05	0.00108	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.98e-05	0.00107	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.9e-05	0.00104	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.87e-05	0.00103	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.82e-05	0.00101	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.75e-05	0.000986	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.73e-05	0.000979	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.62e-05	0.000942	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.55e-05	0.000917	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.55e-05	0.000915	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.52e-05	0.000905	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.5e-05	0.000898	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.49e-05	0.000893	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.42e-05	0.00087	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.42e-05	0.00087	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.39e-05	0.000858	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.36e-05	0.000846	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.32e-05	0.000832	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.3e-05	0.000827	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.28e-05	0.00082	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.28e-05	0.000819	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000789	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.18e-05	0.000783	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.18e-05	0.000781	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.17e-05	0.000778	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.16e-05	0.000777	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.12e-05	0.000762	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.1e-05	0.000756	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.07e-05	0.000743	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TP53—chronic obstructive pulmonary disease	2.06e-05	0.00074	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.98e-05	0.000711	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.97e-05	0.000706	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.93e-05	0.000693	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.93e-05	0.000692	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.91e-05	0.000687	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.9e-05	0.000682	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.89e-05	0.00068	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.86e-05	0.000669	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.84e-05	0.000661	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.84e-05	0.000659	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.77e-05	0.000634	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.76e-05	0.000632	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.75e-05	0.000627	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.71e-05	0.000615	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.57e-05	0.000563	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.56e-05	0.000561	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.45e-05	0.00052	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.44e-05	0.000517	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.43e-05	0.000514	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.41e-05	0.000507	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.41e-05	0.000505	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.38e-05	0.000496	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.34e-05	0.000482	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.32e-05	0.000473	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.000461	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.18e-05	0.000425	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.17e-05	0.00042	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.17e-05	0.00042	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.14e-05	0.000409	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.14e-05	0.000409	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.11e-05	0.000399	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.08e-05	0.000389	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.08e-05	0.000388	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.06e-05	0.00038	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.06e-05	0.00038	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.03e-05	0.00037	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.5e-06	0.000341	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.24e-06	0.000332	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.72e-06	0.000313	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.55e-06	0.000307	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.48e-06	0.000305	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.32e-06	0.000299	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.18e-06	0.000258	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.98e-06	0.000251	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.57e-06	0.000236	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.39e-06	0.000229	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.22e-06	0.000223	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.15e-06	0.000221	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.61e-06	0.000201	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.17e-06	0.000186	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.31e-06	0.000155	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.25e-06	0.000153	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.96e-06	0.000142	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.76e-06	0.000135	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.55e-06	9.17e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.44e-06	8.77e-05	CbGpPWpGaD
